User account
On this page you can display your personal bibliography. To do this do a search of your own publications in PubMed, Google Scholar, or your favorite literature search or management tool. Import all your publications at once using the "Import My Publications" button, or add them one by one by pressing "Add a publication." To import all publications at once, you must use have a BibTex, EndNote, RIS, MARC, XML file of your publications or a list of PubMed IDs.
“Ocular Findings in Patients with the Hermansky-Pudlak Syndrome (Types 1 and 3).”, Ophthalmic Genet, 2014.
“Pharmacogenetic association study of warfarin safety endpoints in Puerto Ricans.”, P R Health Sci J, vol. 33, no. 3, pp. 97-104, 2014.
“Pharmacogenetics of drug-metabolizing enzymes in US Hispanics.”, Drug Metabol Drug Interact, 2014.
“CYP2D6's functional status associated with the length of hospitalization stay in psychiatric patients: a twist in the tale or evidence that matters?”, Biomark Med, vol. 7, no. 6, pp. 913-4, 2013.
“A divalent interaction between HPS1 and HPS4 is required for the formation of the biogenesis of lysosome-related organelle complex-3 (BLOC-3).”, Biochim Biophys Acta, vol. 1833, no. 3, pp. 468-78, 2013.
“Frequencies of Functional Polymorphisms in Three Pharmacokinetic Genes of Clinical Interest within the Admixed Puerto Rican Population.”, J Pharmacogenomics Pharmacoproteomics, vol. 4, no. 113, 2013.
“Ocular findings in patients with oculocutaneous albinism type ia with G47D tyrosinase gene mutation in Puerto Rico: a case report.”, Bol Asoc Med P R, vol. 105, no. 2, pp. 62-4, 2013.
“Development of a pharmacogenetic-guided warfarin dosing algorithm for Puerto Rican patients.”, Pharmacogenomics, vol. 13, no. 16, pp. 1937-50, 2012.
“Dysregulation of macrophage-secreted cathepsin B contributes to HIV-1-linked neuronal apoptosis.”, PLoS One, vol. 7, no. 5, p. e36571, 2012.
“Prediction of warfarin dose reductions in Puerto Rican patients, based on combinatorial CYP2C9 and VKORC1 genotypes.”, Ann Pharmacother, vol. 46, no. 2, pp. 208-18, 2012.
“Asymptomatic child heterozygous for hemoglobin S and hemoglobin Pôrto Alegre.”, Pediatr Blood Cancer, vol. 56, no. 3, pp. 458-9, 2011.
“Nonsense mutations of the bHLH transcription factor TWIST2 found in Setleis Syndrome patients cause dysregulation of periostin.”, Int J Biochem Cell Biol, vol. 43, no. 10, pp. 1523-31, 2011.
“Prevalence of a loss-of-function mutation in the proton-coupled folate transporter gene (PCFT-SLC46A1) causing hereditary folate malabsorption in Puerto Rico.”, J Pediatr, vol. 159, no. 4, pp. 623-7.e1, 2011.
“Redundant or separate entities?--roles of Twist1 and Twist2 as molecular switches during gene transcription.”, Nucleic Acids Res, vol. 39, no. 4, pp. 1177-86, 2011.
“CYP2C9 and VKORC1 genotypes in Puerto Ricans: A case for admixture-matching in clinical pharmacogenetic studies.”, Clin Chim Acta, vol. 411, no. 17-18, pp. 1306-11, 2010.
“Homozygous nonsense mutations in TWIST2 cause Setleis syndrome.”, Am J Hum Genet, vol. 87, no. 2, pp. 289-96, 2010.
“MTHFR polymorphisms in Puerto Rican children with isolated congenital heart disease and their mothers.”, Int J Genet Mol Biol, vol. 2, no. 3, pp. 43-47, 2010.
“Newborn screening for hermansky-pudlak syndrome type 3 in Puerto Rico.”, J Pediatr Hematol Oncol, vol. 32, no. 6, pp. 448-53, 2010.
“Recombinant hemoglobin II from Lucina pectinata: a large-scale method for hemeprotein expression in E. coli.”, Protein J, vol. 29, no. 2, pp. 143-51, 2010.
“Restricted HIV-1 replication in placental macrophages is caused by inefficient viral transcription.”, J Leukoc Biol, vol. 87, no. 4, pp. 633-6, 2010.
“Factors controlling the reactivity of hydrogen sulfide with hemeproteins.”, Biochemistry, vol. 48, no. 22, pp. 4881-94, 2009.
“For the patient. DNA makeup of Hispanic persons should be determined before warfarin prescription.”, Ethn Dis, vol. 19, no. 4, pp. 479-80, 2009.
“Physiogenomic analysis of the Puerto Rican population.”, Pharmacogenomics, vol. 10, no. 4, pp. 565-77, 2009.
“Prevalence of combinatorial CYP2C9 and VKORC1 genotypes in Puerto Ricans: implications for warfarin management in Hispanics.”, Ethn Dis, vol. 19, no. 4, pp. 390-5, 2009.